This market allows you to be on the market cap on Dec 31, 2030, of following four companies:

Ginkgo Bioworks ($2.54b*), with a focus on cell programming, has shown potential in markets from agriculture to pharmaceuticals, offering scalable solutions for genetic engineering.

Recursion Pharmaceuticals ($2.62b*), leveraging AI and automation for drug discovery, targets a vast space of untreatable diseases, promising significant growth.

Twist Bioscience ($2.20b*) specializing in synthetic DNA, presents a scalable model with projected strong revenue growth, indicating its capability to capture market share in genomics.

10x Genomics ($4.88b*) is a biotechnology company that specializes in developing products and systems for single-cell analysis and genomics, aiming to enhance scientific research and clinical health diagnostics.

*Market cap in March 8, 2024